BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

823 related articles for article (PubMed ID: 17315946)

  • 1. Conjugation of arginine-glycine-aspartic acid peptides to poly(ethylene oxide)-b-poly(epsilon-caprolactone) micelles for enhanced intracellular drug delivery to metastatic tumor cells.
    Xiong XB; Mahmud A; Uludağ H; Lavasanifar A
    Biomacromolecules; 2007 Mar; 8(3):874-84. PubMed ID: 17315946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of block copolymer structure on the internalization of polymeric micelles by human breast cancer cells.
    Mahmud A; Lavasanifar A
    Colloids Surf B Biointerfaces; 2005 Oct; 45(2):82-9. PubMed ID: 16144761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decoration of polymeric micelles with cancer-specific peptide ligands for active targeting of paclitaxel.
    Shahin M; Ahmed S; Kaur K; Lavasanifar A
    Biomaterials; 2011 Aug; 32(22):5123-33. PubMed ID: 21501865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic RGDyK conjugation facilitates intracellular drug delivery of polymeric micelles to integrin-overexpressing tumor cells and neovasculature.
    Yin J; Li Z; Yang T; Wang J; Zhang X; Zhang Q
    J Drug Target; 2011 Jan; 19(1):25-36. PubMed ID: 20233083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel self-associating poly(ethylene oxide)-b-poly(epsilon-caprolactone) based drug conjugates and nano-containers for paclitaxel delivery.
    Shahin M; Lavasanifar A
    Int J Pharm; 2010 Apr; 389(1-2):213-22. PubMed ID: 20080163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fine tuning micellar core-forming block of poly(ethylene glycol)-block-poly(ε-caprolactone) amphiphilic copolymers based on chemical modification for the solubilization and delivery of doxorubicin.
    Yan J; Ye Z; Chen M; Liu Z; Xiao Y; Zhang Y; Zhou Y; Tan W; Lang M
    Biomacromolecules; 2011 Jul; 12(7):2562-72. PubMed ID: 21598958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micelles of poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin.
    Ma Z; Haddadi A; Molavi O; Lavasanifar A; Lai R; Samuel J
    J Biomed Mater Res A; 2008 Aug; 86(2):300-10. PubMed ID: 17957721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide modified polymeric micelles specific for breast cancer cells.
    Mathews AS; Ahmed S; Shahin M; Lavasanifar A; Kaur K
    Bioconjug Chem; 2013 Apr; 24(4):560-70. PubMed ID: 23514428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folate-conjugated methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) amphiphilic block copolymeric micelles for tumor-targeted drug delivery.
    Park EK; Kim SY; Lee SB; Lee YM
    J Control Release; 2005 Dec; 109(1-3):158-68. PubMed ID: 16263189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodegradable amphiphilic poly(ethylene oxide)-block-polyesters with grafted polyamines as supramolecular nanocarriers for efficient siRNA delivery.
    Xiong XB; Uludağ H; Lavasanifar A
    Biomaterials; 2009 Jan; 30(2):242-53. PubMed ID: 18838158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
    Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
    J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micelles of methoxy poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization and controlled delivery of cyclosporine A.
    Aliabadi HM; Mahmud A; Sharifabadi AD; Lavasanifar A
    J Control Release; 2005 May; 104(2):301-11. PubMed ID: 15907581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphiphilic toothbrushlike copolymers based on poly(ethylene glycol) and poly(epsilon-caprolactone) as drug carriers with enhanced properties.
    Zhang W; Li Y; Liu L; Sun Q; Shuai X; Zhu W; Chen Y
    Biomacromolecules; 2010 May; 11(5):1331-8. PubMed ID: 20405912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin.
    Xiong XB; Ma Z; Lai R; Lavasanifar A
    Biomaterials; 2010 Feb; 31(4):757-68. PubMed ID: 19818492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(ethylene oxide)-modified poly(epsilon-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer.
    Shenoy DB; Amiji MM
    Int J Pharm; 2005 Apr; 293(1-2):261-70. PubMed ID: 15778064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monolayer-protected gold nanoparticles by the self-assembly of micellar poly(ethylene oxide)-b-poly(epsilon-caprolactone) block copolymer.
    Azzam T; Eisenberg A
    Langmuir; 2007 Feb; 23(4):2126-32. PubMed ID: 17279704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of nonpolar and polar intermolecular interactions in the improvement of the drug loading capacity of PEO-b-PCL with increasing PCL content for two hydrophobic Cucurbitacin drugs.
    Patel SK; Lavasanifar A; Choi P
    Biomacromolecules; 2009 Sep; 10(9):2584-91. PubMed ID: 19655789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Encapsulation of hydrophobic drugs in polymeric micelles through co-solvent evaporation: the effect of solvent composition on micellar properties and drug loading.
    Aliabadi HM; Elhasi S; Mahmud A; Gulamhusein R; Mahdipoor P; Lavasanifar A
    Int J Pharm; 2007 Feb; 329(1-2):158-65. PubMed ID: 17008034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adsorption of poly(ethylene oxide)-b-poly(epsilon-caprolactone) copolymers at the silica-water interface.
    Vangeyte P; Leyh B; Rojas OJ; Claesson PM; Heinrich M; Auvray L; Willet N; Jérôme R
    Langmuir; 2005 Mar; 21(7):2930-40. PubMed ID: 15779968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifunctional polymeric micelles for enhanced intracellular delivery of doxorubicin to metastatic cancer cells.
    Xiong XB; Mahmud A; Uludağ H; Lavasanifar A
    Pharm Res; 2008 Nov; 25(11):2555-66. PubMed ID: 18636321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.